Alnylam's research pact worth up to $1.1B sends Tenaya higher

2026-03-05 08:54:47 ET

More on Alnylam Pharmaceuticals, Tenaya Therapeutics

• Alnylam Pharmaceuticals, Inc. (ALNY) Presents at TD Cowen 46th Annual Health Care Conference Transcript
• Alnylam Hit Hard As Investors Forced To Revise Future Profit Expectations
• Alnylam Pharmaceuticals, Inc. (ALNY) Q4 2025 Earnings Call Transcript
• Alnylam targets 25% revenue CAGR through 2030 amid AMVUTTRA launch momentum and pipeline expansion
• Alnylam Pharmaceuticals Non-GAAP EPS of $1.25 misses by $0.25, revenue of $1.09B misses by $70M

Read the full article on Seeking Alpha

For further details see: